The application of statistical methods using VOCs to identify patients with lung cancer

In this work, an attempt was made to determine a group of lung cancer biomarkers. For this study, breath samples collected from 137 patients with confirmed lung cancer were analyzed by the SPME-GC/MS method. As a reference group, exhaled air from 143 healthy volunteers with different smoking habits (active smokers, passive smokers and nonsmokers) was applied. Statistical methods such as discriminant analysis (DA) and the CHAID model tree were used for data processing and evaluation. In the breath of patients with lung cancer, increased concentration of ethanol, acetone, butane, dimethyl sulfide, isoprene, propanal, 1-propanol, 2-pentanone, furan, o-xylene and ethylbenzene was observed in comparison to healthy nonsmokers. Furthermore, pentanal, hexanal and nonane were identified only in the breath of people who suffered from cancer. DA confirmed the importance of these compounds and allowed us to identify patients with lung cancer from healthy volunteers. In the exhaled air of healthy smokers (passive and active), a higher concentration of acetonitrile, benzene and furan derivatives was observed than in nonsmokers. DA revealed that in order to recognize healthy volunteers with different smoking habits by breath analysis, butyrolactone, carbon disulfide and dimethyl sulfide have to be considered.

[1]  W. Miekisch,et al.  Analysis of exhaled breath for screening of lung cancer patients , 2010 .

[2]  Eugene W. Wang,et al.  The relation of student behavior, peer status, race, and gender to decisions about school discipline using CHAID decision trees and regression modeling. , 2010, Journal of school psychology.

[3]  Ali Serhan Koyuncugil,et al.  Detecting Road Maps for Capacity Utilization Decisions by Clustering Analysis and CHAID Decision Tress , 2010, Journal of Medical Systems.

[4]  M. Fiegl,et al.  Noninvasive detection of lung cancer by analysis of exhaled breath , 2009, BMC Cancer.

[5]  I. Horváth,et al.  Exhaled biomarkers in lung cancer , 2009, European Respiratory Journal.

[6]  B. Buszewski,et al.  Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry. , 2009, Biomedical chromatography : BMC.

[7]  Magdalena Ligor,et al.  Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry , 2009, Clinical chemistry and laboratory medicine.

[8]  H. Birnbaum,et al.  Real-world predictors of surgery in patients with low back pain: a CHAID analysis , 2009 .

[9]  Hye-Jin Sung,et al.  Biomarkers for the lung cancer diagnosis and their advances in proteomics. , 2008, BMB reports.

[10]  Ping Wang,et al.  A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis , 2007, Cancer.

[11]  F. Tittel,et al.  Recent advances of laser-spectroscopy-based techniques for applications in breath analysis , 2007, Journal of breath research.

[12]  Bogusław Buszewski,et al.  Human exhaled air analytics: biomarkers of diseases. , 2007, Biomedical chromatography : BMC.

[13]  Steven A Carr,et al.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.

[14]  Olaf Tietje,et al.  Prediction of breast cancer using volatile biomarkers in the breath , 2006, Breast Cancer Research and Treatment.

[15]  E. Taioli Biomarkers of genetic susceptibility to cancer: applications to epidemiological studies. , 2005, Future oncology.

[16]  Wouter Olthuis,et al.  A hydrogen peroxide sensor for exhaled breath measurement , 2005 .

[17]  R. Nelson,et al.  Investigating diversity in human plasma proteins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  L. Bianchi,et al.  Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study , 2005, Respiratory research.

[19]  P. Montuschi Exhaled breath condensate analysis in patients with COPD. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[20]  P. Lirk,et al.  Medical applications of proton transfer reaction-mass spectrometry: ambient air monitoring and breath analysis , 2004 .

[21]  X. Zhang,et al.  Determination of acetone in human breath by gas chromatography-mass spectrometry and solid-phase microextraction with on-fiber derivatization. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[22]  X. Zhang,et al.  Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[23]  W. Miekisch,et al.  Diagnostic potential of breath analysis--focus on volatile organic compounds. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[24]  V. Ruzsanyi ANALYSIS OF HUMAN BREATH USING IMS , 2004 .

[25]  Anja Vogler,et al.  An Introduction to Multivariate Statistical Analysis , 2004 .

[26]  J. F. Periago,et al.  Application of solid-phase microextraction and gas chromatography-mass spectrometry to the determination of volatile organic compounds in end-exhaled breath samples. , 2003, Journal of chromatography. A.

[27]  T. Mitsui,et al.  Assessing nitrate metabolism in the intestinal tract by measuring breath nitric oxide and nitrous oxide, and its clinical significance. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[28]  S. Bonassi,et al.  Validation of biomarkers as early predictors of disease. , 2001, Mutation research.

[29]  P. Barnes,et al.  Exhaled markers of pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[30]  L. J. Myers,et al.  The scientific foundation and efficacy of the use of canines as chemical detectors for explosives. , 2001, Talanta.

[31]  M. Phillips,et al.  Variation in volatile organic compounds in the breath of normal humans. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[32]  P Rolfe,et al.  The selected ion flow tube (SIFT)--a novel technique for biological monitoring. , 1996, The Annals of occupational hygiene.

[33]  M. Phillips,et al.  Breath tests in medicine. , 1992, Scientific American.

[34]  A. Cailleux,et al.  Blood isoprene concentrations in humans and in some animal species. , 1992, Biochemical medicine and metabolic biology.

[35]  A. Manolis,et al.  The diagnostic potential of breath analysis. , 1983, Clinical chemistry.

[36]  T. W. Anderson,et al.  An Introduction to Multivariate Statistical Analysis , 1959 .